
The Center for Disease Control and Prevention (CDC) today published in the weekly Morbidity and Mortality Weekly Report interim guidance for the use of Preexposure Prophylaxis (PrEP) for the prevention of HIV infection among Injecting Drug Users (IDUs). Results from a randomized controlled trial in Bangkok, Thailand, of a daily oral dose of 300 mg…



